CONMED CORP's ticker is and the CUSIP is 207410AF8. A total of 25 filers reported holding CONMED CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $627,560 | -82.3% | 541,000 | -77.0% | 0.00% | -100.0% |
| Q2 2023 | $3,554,376 | -25.2% | 2,350,000 | -39.8% | 0.00% | 0.0% |
| Q1 2023 | $4,753,875 | -13.0% | 3,901,000 | -17.5% | 0.00% | -50.0% |
| Q4 2022 | $5,465,288 | -6.0% | 4,726,000 | -10.5% | 0.00% | 0.0% |
| Q3 2022 | $5,816,000 | -36.4% | 5,281,000 | -30.2% | 0.00% | -33.3% |
| Q2 2022 | $9,144,000 | -25.3% | 7,565,000 | +6.2% | 0.00% | 0.0% |
| Q1 2022 | $12,245,000 | -6.7% | 7,121,000 | -9.8% | 0.00% | 0.0% |
| Q4 2021 | $13,124,000 | -56.2% | 7,894,000 | -59.3% | 0.00% | -57.1% |
| Q3 2021 | $29,995,000 | +27.9% | 19,407,000 | +33.3% | 0.01% | +40.0% |
| Q2 2021 | $23,460,000 | +23.5% | 14,560,000 | +19.9% | 0.01% | +25.0% |
| Q1 2021 | $18,989,000 | +82.6% | 12,148,000 | +63.3% | 0.00% | +33.3% |
| Q4 2020 | $10,398,000 | +6522.9% | 7,438,000 | +5212.9% | 0.00% | – |
| Q3 2020 | $157,000 | +6.8% | 140,000 | 0.0% | 0.00% | – |
| Q2 2020 | $147,000 | – | 140,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABSOLUTE INVESTMENT ADVISERS, LLC | 4,035,000 | $4,888,000 | 0.98% |
| III Capital Management | 3,669,000 | $4,453,000 | 0.41% |
| SHENKMAN CAPITAL MANAGEMENT INC | 3,972,000 | $4,789,000 | 0.29% |
| MACKAY SHIELDS LLC | 6,783,000 | $8,195,000 | 0.20% |
| Warberg Asset Management LLC | 722,000 | $875,000 | 0.19% |
| ZAZOVE ASSOCIATES LLC | 1,628,000 | $1,967,000 | 0.19% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,564,000 | $4,312,000 | 0.12% |
| Teton Advisors, Inc. | 350,000 | $423,000 | 0.09% |
| Calamos Wealth Management LLC | 823,000 | $998,000 | 0.09% |
| WESTWOOD HOLDINGS GROUP INC | 4,310,000 | $5,263,000 | 0.06% |